@article{1ca3709a5a34426e9ea60f5acc388f35,
title = "Clinical Observation of Improved Outcomes of Patients With BRCA 1/2 Breast Cancer Treated With Everolimus Prior to DNA-Damaging Therapy",
author = "Anderson, \{Matthew R.\} and Denson, \{Aaron C.\} and Saif Zaman and Han, \{Hyo S.\} and Soliman, \{Hatem H.\}",
note = "The mammalian target of rapamycin (mTOR) pathway comprises mTOR complexes 1 and 2 (mTORC1/2) and is primarily responsible for maintaining cellular growth and proliferation. mTORC1 specifically functions in organelle development and aids in the development of ribosomes and macromolecules, fostering lipogenesis.",
year = "2018",
month = aug,
day = "31",
doi = "10.1200/PO.18.00123",
language = "American English",
journal = "JCO Precision Oncology",
number = "2",
}